You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 11, November 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CORRESPONDENCE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corneal Endothelial Toxicity of DexSol Corneal Storage Medium Supplemented With Povidone-Iodine

Francisco J. Garcia-Ferrer, MD; Patrick R. Murray, PhD; Jay S. Pepose, MD, PhD
St Louis, Mo

Arch Ophthalmol. 1992;110(11):1519-1520.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Bacterial endophthalmitis is a dreaded and often visually devastating complication of penetrating keratoplasty. Current methods to achieve antisepsis of donor corneal tissue, such as the addition of gentamicin to the corneal storage media, have had a suboptimal effect. At the storage temperature of 4°C gentamicin provides only limited coverage against gram-positive bacteria, such as Streptococcus pneumoniae.1 In comparison with antibiotics, povidoneiodine is a broad-spectrum disinfectant with rapid activity against bacteria, fungi, viruses, protozoa, and spores.2 We therefore chose to investigate the antimicrobial spectrum and corneal endothelial toxicity of povidone-iodine in DexSol corneal storage medium (Chiron, Irvine, Calif).

The corneal endothelial toxicity of DexSol supplemented with gentamicin (100 µg/mL) was compared with that of DexSol supplemented with either 5%, 1%, or 0.1% povidoneiodine without gentamicin using paired human donor corneas. For each corneal pair, one cornea was placed in standard DexSol with gentamicin, and the other . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.